| Home \ Conferences and Programmes \ Health and Welfare |
|
Health and Welfare
 Search for: in: Saving the Health of the Nation. After 10 years of Labour where are we now?
Date: 19 March 2008
Location: Social Market Foundation Conference Room Speakers: Nick Timmins, Geraint Day, Stephen Pollard and Liz Kendall The event will focus on healthcare reform over the last 10 years with a focus on where we go from here. Topics such as Health Savings Accounts, New Labour health reform and whether the NHS really is the sacred cow of British politics will be discussed.
The event will also include a showing of a new 10 minute DVD, produced by the Stockholm Network, entitled `Saving the Health of the Nation: An Introduction to Health Savings Accounts`. The panel will consist of:  Cost Pressures on the German Health System - Is Health Technology Assessment the Solution?
Date: 12 March 2008
Location: Kleiner Festsaal, Hackesche Höfe, Rosenthaler Strasse 40/41, D-10178 Berlin Speakers: Prof. Dr. Frank Lichtenberg, Dr. Christian Behles, Kristian Niemietz Health expenditure in Germany is experiencing dramatic growth. Health Technology Assessment (HTA), the systematic appraisal of the costs and benefits of a medical treatment, is presented as an objective and scientific way to address this dilemma. Independent professional institutions like IQWiG, so its proponents argue, can systematically and objectively assess which medicines should be financed by the public purse, and which can be rejected on the basis of high costs and low benefits to the patients. However, the adoption of HTA throughout the developed world raises some important but often overlooked questions. To what extent are HTA systems an objective and scientific tool, and to what extent just another political construct aimed at the systematic rationing of medicines? Why has the phenomenon escaped vigorous public attention? Is HTA compatible with the goals of patient choice and therapeutic autonomy? And finally how does its use affect the future development of new and innovative healthcare technologies? All these questions and more will be discussed in this event We very much hope you can join us. If you would like to RSVP for this event, please register online below or alternatively email kristian@stockholm-network.org. Please note that this event will be simultaneously translated. Kostenexplosion im deutschen Gesundheitswesen – Sind Kosten-Nutzen-Bewertungen eine Lösung?
Date: 12 March 2008
Location: Festsaal, Hackesche Höfe, Rosenthaler Strasse 40/41, 10178 Berlin Speakers: Prof. Dr. Frank Lichtenberg, Dr. Christian Behles, Kristian Niemietz Die deutschen Gesundheitsausgaben steigen dramatisch an. Vor diesem Hintergrund wird Gesundheitstechnologiebewertung (auch Health Technology Assessment oder HTA), also die systematische Bewertung von Kosten und Nutzen einer medizinischen Leistung, als eine objektive und wissenschaftliche Antwort auf dieses Dilemma dargestellt. Unabhängige Institutionen wie das IQWiG, so behaupten Befürworter, könnten objektiv bewerten, welche Medikamente aus öffentlichen Mitteln finanziert werden sollen, und welche aufgrund hoher Kosten und geringem Nutzen für den Patienten abgelehnt werden können. Die zunehmende Verwendung von HTA wirft wichtige, aber selten beachtete Fragen auf. Ist HTA wirklich ein objektives und wissenschaftliches Instrument, oder dient es lediglich der Rationierung von Gesundheitsleistungen? Warum konnte sich dieses Phänomen bislang einer kritischen öffentlichen Debatte entziehen? Ist HTA vereinbar mit Wahlfreiheit für Patienten und therapeutischer Autonomie für Ärzte? Und welche Auswirkungen hat HTA auf den künftigen medizinischen Fortschritt? Über diese und andere Fragen wird auf unserer Veranstaltung diskutiert werden. Über Ihre Teilnahme würden wir uns freuen. Anmelden können Sie sich, indem Sie weiter unten das Formular ausfüllen, oder eine formlose Anmeldung an kristian@stockholm-network.org senden. Eine Simultanuebersetzung Englisch-Deutsch wird bereitgestellt. When health scares become our daily meal
Date: 15 January 2008
Location: RADISSON SAS EU HOTEL, Rue d’Idalie 35, Brussels, 12.30pm – 1.30pm Speakers: Nathalie Moll and Dr William Durodie When did you last have a GMO breakfast? Unless you carefully checked the ingredients, chances are you have ingested genetically modified cereals recently. How much of a problem is this? The media incites us to greet unidentified risks with great caution: the policy equivalent is the precautionary principle. This entails considerable regulation and safety precautions for the general public until any untested product or technology has been proven harmless. The approach is seemingly common sense: better safe than sorry. This can, however, put a straitjacket on research and scientific inquiry overall. GMO crops are a case in point: these have been in use for 20 years and not a single health incident has been reported. Yet, national and EU authorities have decided that the technology which has the potential of saving millions of people from death by starvation must be suspended. Risk management in modern societies is increasingly not based on a reasonable evaluation of probabilities. Instead it is dictated by the potentially disastrous consequences of unlikely events and infinitesimal risks. This calculus is made essentially on political, rather than scientific criteria. Amigo Society: "Can a Healthy Society be Consistent with “Modern” Values?”
Date: 18 September 2007
Location: Hotel Amigo, Rue de l’Amigo 1-3, Brussels Speakers: Helen Disney (chair), Riel Miller, Johan Hjertqvist What do obesity and terrorism have in common? What do doctors and mechanics have in common? What chance is there that improving the management of the health care system will reduce current problems? Is real-time, place specific, genetically matched epidemiology feasible? What would it achieve?
All of these questions are impossible to answer, since the future does not exist and there are no grounds for predicting it. What can be addressed is the way we see the present and the way we build up the assumptions that shape our choices. The aim of this talk is to examine how the way we think about the future influences the choices we make by imagining other ways of describing the potential of the present. The elements of a few scenarios will be sketched and used to examine current anticipatory assumptions. Coincidence or Crisis Launch - Italy
Date: 12 December 2006
Location: Rome - Ristorante Romilo (12:30) Speakers: Graham Satchwell The business of creating, distributing and selling counterfeit pharmaceutical products is an unregulated, criminal and growing part of the global economy. There is one major difference between pharmaceutical counterfeiting and other underground industries: lives are at stake.
Coincidence or Crisis brings together some of the world’s leading experts to discuss the growth of counterfeit pharmaceuticals. It provides a comprehensive analysis of the core issues, while delimiting key strategies to tackle the problem. Coincidence or Crisis Book Launch
Date: 07 December 2006
Location: Hotel Hilton Slussen, Stockholm, Sweden Speakers: Kerstin Hjalmarsson (Läkemedelsverket), Finn Bengtsson, riksdagsledamot (m), Inger Näsman (Läkemedelsindustriföreningen) Peter Pitts, og Graham Satchwell (författare och brittisk säkerhetsexpert). Handeln med förfalskade läkemedel har ökat under de senaste åren, och även om Sverige hittills varit relativt förskonat vet vi inget om framtiden. Sätten att förfalska läkemedel är otaliga och risken att bli upptäckt liten. Att förfalskade läkemedel når Sverige via den vanliga läkemedelsimporten och i slutändan hamnar på de vanliga apotekens hyllor är ingen omöjlighet. Detta har exempelvis redan inträffat i Storbritannien.
Boken Coincidence or Crisis? beskriver problemet med läkemedelsförfalskning, dess omfattning och möjliga lösningar ur ett europeiskt perspektiv. Boken presenteras av Graham Satchwell som är en av författarna. Efteråt följer en paneldiskussion om läget i Sverige och de internationella erfarenheterna. Hur allvarligt är problemet med illegala läkemedel och läkemedelsförfalskning och hur kan vi lära oss av andra länders erfarenheter? Coincidence or Crisis Launch - Belgium
Date: 06 December 2006
Location: Renaissance Hotel, Rue du Parnasse 19, Brussels. 1230-1430 Speakers: Peter Pitts, Graham Satchwell The business of creating, distributing and selling counterfeit pharmaceutical products is an unregulated, criminal and growing part of the global economy. There is one major difference between pharmaceutical counterfeiting and other underground industries: lives are at stake.
Coincidence or Crisis brings together some of the world’s leading experts to discuss the growth of counterfeit pharmaceuticals. It provides a comprehensive analysis of the core issues, while delimiting key strategies to tackle the problem. Coincidence or Crisis Book Launch - Germany, in association with the Institut fur Unternehmerische Freiheit
Date: 25 October 2006
Location: Institut für Unternehmerische Freiheit, Rosenthaler Str. 40/41, 10178 Berlin, 7pm Speakers: Peter Pitts The business of creating, distributing and selling counterfeit pharmaceutical products is an unregulated, criminal and growing part of the global economy. There is one major difference between pharmaceutical counterfeiting and other underground industries: lives are at stake.
Coincidence or Crisis brings together some of the world’s leading experts to discuss the growth of counterfeit pharmaceuticals. It provides a comprehensive analysis of the core issues, while delimiting key strategies to tackle the problem. Patient mobility in Europe: Filling the void where public systems fail
Date: 26 September 2006
Location: Hotel Amigo, Brussels Speakers: Rudi Thomaes and Johan Hjertqvist EU citizens travel more and more inside the Union, sometimes taking up residence outside of their country of origin for work, leisure or retirement. They are increasingly used to crossing frontiers, buying goods and services wherever they are. Mobile Europeans are also consumers of health care. As this mobility puts pressure on public systems, cross-border agreements have become necessary and they often offer innovative ideas for improving services.These include the euregios insurance cooperation, public/private contracting in tourist areas and hospital cooperation.
Is this nascent “shopping around” a sign of increased competition? How do public systems respond to health tourism? Is it a trend or a marginal phenomenon? |
